Works by Fleischmann, Roy M.

Results: 14

Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1).

Published in:

Rheumatology, 2020, v. 59, n. 10, p. 2774, doi. 10.1093/rheumatology/kez684

By:

Chandran, Vinod;
Heijde, Désirée van der;
Fleischmann, Roy M;
Lespessailles, Eric;
Helliwell, Philip S;
Kameda, Hideto;
Burgos-Vargas, Ruben;
Erickson, Janelle S;
Rathmann, Suchitrita S;
Sprabery, Aubrey Trevelin;
Birt, Julie A;
Shuler, Catherine L;
Gallo, Gaia

Publication type:

Article

A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis.

Published in:

Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1676-y

By:

Fleischmann, Roy M.;
Alten, Rieke;
Pileckyte, Margarita;
Lobello, Kasia;
Hua, Steven Y.;
Cronenberger, Carol;
Alvarez, Daniel;
Bock, Amy E.;
Sewell, K. Lea

Publication type:

Article

A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial.

Published in:

2016

By:

Cutolo, Maurizio;
Myerson, Gary E.;
Fleischmann, Roy M.;
Lioté, Frédéric;
Díaz-González, Federico;
Van den Bosch, Filip;
Marzo-Ortega, Helena;
Feist, Eugen;
Shah, Kamal;
ChiaChi Hu;
Stevens, Randall M.;
Poder, Airi;
Hu, ChiaChi

Publication type:

journal article

Treatment of early rheumatoid arthritis.

Published in:

Modern Rheumatology, 2005, v. 15, n. 3, p. 153, doi. 10.3109/s10165-005-0383-0

By:

Fleischmann, Roy M.;
Stern, Richard L.;
Iqbal, Imran

Publication type:

Article

A Phase II Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.

Published in:

Arthritis & Rheumatology, 2019, v. 71, n. 7, p. 1056, doi. 10.1002/art.40840

By:

Fleischmann, Roy M.;
Vaeterlein, Ole;
Kaeley, Gurjit S.;
Bliddal, Henning;
Blanco, Francisco J.;
Schnitzer, Thomas J.;
Peterfy, Charles;
Chen, Su;
Wang, Li;
Feng, Sheng;
Liu, Wei;
Kosloski, Matthew P.;
Levy, Gwen;
Zhang, Lanju;
Medema, Jeroen K.;
Levesque, Marc C.;
Conaghan, Philip G.;
Berenbaum, Francis;
Pelletier, Jean‐Pierre;
Martel‐Pelletier, Johanne

Publication type:

Article

Safety, Tolerability, and Pharmacodynamics of ABT-122, a Tumor Necrosis Factor- and Interleukin-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With Rheumatoid Arthritis.

Published in:

Arthritis & Rheumatology, 2017, v. 69, n. 12, p. 2283, doi. 10.1002/art.40319

By:

Fleischmann, Roy M.;
Wagner, Frank;
Kivitz, Alan J.;
Mansikka, Heikki T.;
Khan, Nasser;
Othman, Ahmed A.;
Khatri, Amit;
Hong, Feng;
Jiang, Ping;
Ruzek, Melanie;
Padley, Robert J.

Publication type:

Article

A Randomized, Double-Blind, Placebo-Controlled, Twelve-Week, Dose-Ranging Study of Decernotinib, an Oral Selective JAK-3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis.

Published in:

Arthritis & Rheumatology, 2015, v. 67, n. 2, p. 334, doi. 10.1002/art.38949

By:

Fleischmann, Roy M.;
Damjanov, Nemanja S.;
Kivitz, Alan J.;
Legedza, Anna;
Hoock, Thomas;
Kinnman, Nils

Publication type:

Article

Long-term efficacy, safety, and immunogenicity of the adalimumab biosimilar, PF-06410293, in patients with rheumatoid arthritis after switching from reference adalimumab (Humira®) or continuing biosimilar therapy: week 52–92 data from a randomized, double-blind, phase 3 trial

Published in:

Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02626-4

By:

Fleischmann, Roy M.;
Alvarez, Daniel F.;
Bock, Amy E.;
Cronenberger, Carol;
Vranic, Ivana;
Zhang, Wuyan;
Alten, Rieke

Publication type:

Article

Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity.

Published in:

Arthritis Research & Therapy, 2015, v. 17, p. 1, doi. 10.1186/s13075-015-0849-1

By:

Pope, Janet;
Bingham III, Clifton O.;
Fleischmann, Roy M.;
Dougados, Maxime;
Massarotti, Elena M.;
Wollenhaupt, Jürgen;
Duncan, Benjamin;
Coteur, Geoffroy;
Weinblatt, Michael E.

Publication type:

Article

Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis.

Published in:

Rheumatology & Therapy, 2022, v. 9, n. 3, p. 839, doi. 10.1007/s40744-022-00439-8

By:

Fleischmann, Roy M.;
Bock, Amy E.;
Zhang, Wuyan;
Godfrey, Charles M.;
Vranic, Ivana;
Cronenberger, Carol;
Dokoupilová, Eva

Publication type:

Article

Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial.

Published in:

2016

By:

Emery, Paul;
Fleischmann, Roy M.;
Strusberg, Ingrid;
Durez, Patrick;
Nash, Peter;
Amante, Eric Jason B.;
Churchill, Melvin;
Park, Won;
Pons-Estel, Bernardo;
Han, Chenglong;
Gathany, Timothy A.;
Xu, Stephen;
Zhou, Yiying;
Leu, Jocelyn H.;
Hsia, Elizabeth C.

Publication type:

journal article

Golimumab, a human anti–tumor necrosis factor monoclonal antibody, injected subcutaneously every 4 weeks in patients with active rheumatoid arthritis who had never taken methotrexate: 1-year and 2-year clinical, radiologic, and physical function findings of a phase III, multicenter, randomized, double-blind, placebo-controlled study.

Published in:

2013

By:

Emery, Paul;
Fleischmann, Roy M;
Doyle, Mittie K;
Strusberg, Ingrid;
Durez, Patrick;
Nash, Peter;
Amante, Eric;
Churchill, Melvin;
Park, Won;
Pons-Estel, Bernardo;
Xu, Weichun;
Xu, Stephen;
Wu, Zhong;
Hsia, Elizabeth C

Publication type:

journal article

Golimumab, a Human Anti-Tumor Necrosis Factor Monoclonal Antibody, Injected Subcutaneously Every 4 Weeks in Patients With Active Rheumatoid Arthritis Who Had Never Taken Methotrexate: 1-Year and 2-Year Clinical, Radiologic, and Physical Function Findings of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Published in:

Arthritis Care & Research, 2013, v. 65, n. 11, p. 1732, doi. 10.1002/acr.22072

By:

Emery, Paul;
Fleischmann, Roy M.;
Doyle, Mittie K.;
Strusberg, Ingrid;
Durez, Patrick;
Nash, Peter;
Amante, Eric;
Churchill, Melvin;
Park, Won;
Pons-Estel, Bernardo;
Xu, Weichun;
Xu, Stephen;
Wu, Zhong;
Hsia, Elizabeth C.

Publication type:

Article

Safety and efficacy of etanercept beyond 10 years of therapy in North American patients with early and longstanding rheumatoid arthritis.

Published in:

Arthritis Care & Research, 2011, v. 63, n. 3, p. 373, doi. 10.1002/acr.20372

By:

Weinblatt, Michael E.;
Bathon, Joan M.;
Kremer, Joel M.;
Fleischmann, Roy M.;
Schiff, Michael H.;
Martin, Richard W.;
Baumgartner, Scott W.;
Park, Grace S.;
Mancini, Edward L.;
Genovese, Mark C.

Publication type:

Article